Form 144/A ARROWHEAD PHARMACEUTICAL Filed by: Apel Daniel Joseph
Tweet
Share
E-mailATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU approves Arrowhead's plozasiran for rare triglyceride disorder
- Global Times: Protecting Nyang River in Xizang, a practice in building a Beautiful China on snowy plateau
- ees Europe 2026: XING Mobility Makes European Debut of XBE50 Immersion-Cooled Mobile Power Solution
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
